Biocryst Pharmaceuticals buy TD Cowen
Start price
15.10.25
/
50%
€5.62
Target price
15.10.26
€25.82
Performance (%)
43.51%
Price
17.04.26
€8.07
Summary
This prediction is currently active. With a performance of 43.51% the BUY prediction by TD_Cowen is a big success. This prediction currently runs until 15.10.26. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -1.103% | -1.103% |
| iShares Core DAX® | 3,59 % | 6,43 % |
| iShares Nasdaq 100 | 5,81 % | 6,38 % |
| iShares Nikkei 225® | 4,08 % | 9,31 % |
| iShares S&P 500 | 4,14 % | 4,94 % |
Comments by TD_Cowen for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at TD Cowen. They set a "buy" rating and a $30.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat